Seeking Alpha

BIND Therapeutics EPS of -$2.70, beats on revenues

  • BIND Therapeutics (BIND): Q3 EPS of -$2.70.
  • Revenue of $4.6M beats by $2.94M. (PR)

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs